CJC-1295 is not FDA approved as a standard treatment for muscle growth, fat loss, anti-aging, athletic performance, or general wellness
Beyond fat loss, Tesamorelin increases lean body mass by 1.42 kg across randomized clinical trials, improves lipid profiles (reducing triglycerides by 48 mg/dL and total cholesterol by 8 mg/dL at 52 weeks), and lowers hepatic fat fraction by 4.9% at 12 months in patients with NAFLD
Compounded liraglutide should be used only under the guidance of a qualified healthcare provider, with ongoing monitoring
By bypassing the digestive system, these wellness injections allow your body to absorb nutrients quickly and efficiently
Some patients express concern about developing a lump in the neck whilst taking this medication, often due to pre-clinical animal studies linking GLP-1 agonists to thyroid C-cell tumours